CAR T 细胞疗法

打印

科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业，通过齐心协力确保高品质治疗与成功康复。

有相关专长的科室

研究此手术的领域

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

  1. Sikander Ailawadhi, M.D.

    Sikander Ailawadhi, M.D.

    1. Oncologist
    1. Jacksonville, FL
    擅长领域：

    CAR-T cell therapy, Multiple myeloma, Leukemia, Chronic lymphocytic leukemia, Waldenstrom macroglobulinemia, Macroglobu...linemia, Chronic myelogenous leukemia, Plasma cell disorders, Follicular lymphoma, B-cell lymphoma, Marginal zone lymphoma

  2. Muhamad Alhaj Moustafa, M.D., M.S.

    Muhamad Alhaj Moustafa, M.D., M.S.

    1. Oncologist
    2. Hematologist
    1. Jacksonville, FL
    擅长领域：

    Chemotherapy, Immunotherapy, Bone marrow biopsy and aspiration, CAR-T cell therapy, Cellular therapy, Lymphoma, Non-Hod...gkin lymphoma, Hodgkin lymphoma, Hairy cell leukemia, Cutaneous t-cell lymphoma, Cutaneous b-cell lymphoma, Diffuse large b-cell lymphoma, Follicular lymphoma, Small lymphocytic lymphoma, B-cell lymphoma, T-cell lymphoma

  3. Hassan Alkhateeb, M.D.

    Hassan Alkhateeb, M.D.

    1. Hematologist
    1. Rochester, MN
    擅长领域：

    CAR-T cell therapy, Autologous stem cell transplant, Allogeneic stem cell transplant, Acute lymphocytic leukemia, Acute... myelogenous leukemia, Myelodysplastic syndromes, Myeloproliferative disorders, Graft versus host disease

  4. Stephen M. Ansell, M.D., Ph.D.

    Stephen M. Ansell, M.D., Ph.D.

    1. Internist
    2. Oncologist
    3. Hematologist
    1. Rochester, MN
    擅长领域：

    CAR-T cell therapy, Non-Hodgkin lymphoma, Hodgkin lymphoma, Follicular lymphoma, Burkitt lymphoma, B-cell lymphoma

  5. Steven Attia, D.O.

    Steven Attia, D.O.

    1. Oncologist
    1. Jacksonville, FL
    擅长领域：

    CAR-T cell therapy, Bone cancer, Neurofibromatosis, Rhabdomyosarcoma, Chordoma, Soft tissue sarcoma, Gastrointestinal s...tromal tumor, Desmoid tumor, Giant cell tumor, Benign bone tumor, Pigmented villonodular synovitis

  6. Ernesto Ayala, M.D.

    Ernesto Ayala, M.D.

    1. Jacksonville, FL
    擅长领域：

    CAR-T cell therapy, Bone marrow transplant, Autologous stem cell transplant, Allogeneic stem cell transplant, Acute lym...phocytic leukemia, Acute myelogenous leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Follicular lymphoma, Burkitt lymphoma, Graft versus host disease, B-cell lymphoma, T-cell lymphoma

  7. N. Nora Bennani, M.D.

    N. Nora Bennani, M.D.

    1. Internist
    2. Oncologist
    3. Hematologist
    1. Rochester, MN
    擅长领域：

    CAR-T cell therapy, Lymphoma, Cutaneous t-cell lymphoma, Follicular lymphoma, B-cell lymphoma, T-cell lymphoma

  8. Matthew S. Block, M.D., Ph.D.

    Matthew S. Block, M.D., Ph.D.

    1. Oncologist
    1. Rochester, MN
    擅长领域：

    CAR-T cell therapy, Biological therapy for cancer, Melanoma, Gynecologic cancer

  9. Asher A. Chanan-Khan, M.D.

    Asher A. Chanan-Khan, M.D.

    1. Hematologist
    1. Jacksonville, FL
    擅长领域：

    CAR-T cell therapy, Melanoma, Multiple myeloma, Chronic lymphocytic leukemia, Waldenstrom macroglobulinemia

  10. Saranya Chumsri, M.D.

    Saranya Chumsri, M.D.

    1. Oncologist
    1. Jacksonville, FL
    擅长领域：

    CAR-T cell therapy, Breast cancer

研究

妙佑医疗国际的医生和研究人员正在研究改善血癌治疗方案的方法，包括 CAR-T 细胞疗法和其他癌症治疗创新。

血癌研究系与妙佑医疗国际综合癌症中心合作开展。妙佑医疗国际综合癌症中心接受美国国家癌症研究所资金，是指定的综合癌症中心。这是对该机构在癌症预防、诊断和治疗方面的卓越科学成就和多学科资源的认可。

著述

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际的医生在 CAR-T 细胞疗法领域的著述目录。

Research Profiles

来自妙佑医疗国际员工

在 Mayo Clinic 治疗

关于在 Mayo Clinic 治疗
Nov. 14, 2025
打印
  1. Brudno JN, et al. CAR T cells and T-cell therapies for cancer. JAMA. 2024; doi:10.1001/jama.2024.19462.
  2. CAR T cells: Engineering patients' immune cells to treat their cancers. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/research/car-t-cells. Accessed April 16, 2025.
  3. Kymriah (prescribing information). Novartis; 2024. https://us.kymriah.com. Accessed April 24, 2025.
  4. Yescarta (prescribing information). Kite Pharma; 2024. https://www.yescartahcp.com. Accessed April 24, 2025.
  5. Tecartus (prescribing information). Kite Pharma; 2024. https://www.tecartushcp.com. Accessed April 24, 2025.
  6. Breyanzi (prescribing information). Bristol Myers Squibb; 2024. https://www.breyanzihcp.com. Accessed April 24, 2025.
  7. Abecma (prescribing information). Bristol Myers Squibb; 2024. https://www.abecma.com/. Accessed April 24, 2025.
  8. Carvykti (prescribing information). Janssen Biotech; 2024. https://www.carvykti.com. Accessed April 24, 2025.
  9. Aucatzyl (prescribing information). Autolus; 2024. https://www.autolus.com. Accessed April 24, 2025.
  10. Roddie C, et al. Obecabtagene autoleucel in adults with B-cell acute lymphoblastic leukemia. New England Journal of Medicine. 2024; doi:10.1056/NEJMoa2406526.
  11. Immunotherapy side effects: CAR T-cell therapy. National Comprehensive Cancer Network. http://www.NCCN.org/patientguidelines. Accessed April 16, 2025.
  12. Hines MR, et al. Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome. Transplantation and Cellular Therapy. 2023; doi:10.1016/j.jtct.2023.03.006.
  13. Amini L, et al. Preparing for CAR T cell therapy: Patient selection, bridging therapies and lymphodepletion. Nature Reviews: Clinical Oncology. 2022; doi:10.1038/ s41571-022-00607-3.
  14. Steinbach M, et al. Nursing care throughout the chimeric antigen receptor T-cell therapy process for multiple myeloma. Seminars in Oncology Nursing. 2023; doi:10.1016/j.soncn.2023.151505.
  15. Acute lymphoblastic leukemia. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1410. Accessed April 22, 2025.
  16. B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480. Accessed April 22, 2025.
  17. Chronic lymphocytic leukemia. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1478. Accessed April 22, 2025.
  18. Multiple myeloma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1445. Accessed April 22, 2025.
  19. Shoushtari AN, et al. Principles of cancer immunotherapy. https://www.uptodate.com/contents/search. Accessed April 21, 2025.
  20. T-cell transfer therapy. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy. Accessed April 24, 2025.
  21. Health Education & Content Services. Chimeric antigen receptor T-cell (CAR-T) therapy. Mayo Clinic; 2019.
  22. Bashir Q, et al., eds. Process and general management of patients undergoing chimeric antigen receptor therapies. In: Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Elsevier; 2024. https://www.clinicalkey.com. Accessed May 1, 2025.
  23. Neelapu SS, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. New England Journal of Medicine. 2017; doi:10.1056/NEJMoa1707447.

相关

Mayo Clinic 新闻

产品与服务

CAR T 细胞疗法